Wahlstrom Mats 4
4 · TriSalus Life Sciences, Inc. · Filed Nov 22, 2024
Insider Transaction Report
Form 4
Wahlstrom Mats
Director10% Owner
Transactions
- Purchase
Common Stock
2024-11-21$4.44/sh+8,687$38,570→ 10,727 total - Purchase
Common Stock
2024-11-20$4.16/sh+2,040$8,486→ 2,040 total
Holdings
- 1,254,259(indirect: By LLC)
Common Stock
- 1,370,028(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.99 to $4.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.19 to $4.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F3]The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.
- [F4]The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.